# Nick Smith

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/nick-smith
Canonical HTML page: https://getbiobrief.com/entity/nick-smith

## Timeline

- **2026-03-23**: CFO Briefing — CFO Nick Smith discusses the strategic implications of the $120M financing for the firm's pipeline.
- **2026-03-16**: Earnings & Funding — Alto reports Q4 earnings beating EPS estimates and announces the $120M private placement.
- **2026-03-11**: 1-Year High — ANRO stock hits a new 52-week high amid positive sentiment in the psychiatric therapy market.

## Recent coverage (1 stories)

### Alto Neuroscience Secures $120M to Advance Precision Psychiatry Pipeline
2026-03-24 00:43:47 · Sentiment: Positive · Impact: 6/10 · Sources: 3

Alto Neuroscience has completed a $120 million private placement financing to accelerate its biomarker-driven clinical programs. Led by CFO Nick Smith, the capital injection extends the company's cash runway through critical Phase 2b readouts in depression and schizophrenia.
Full story: https://getbiobrief.com/story/alto-neuroscience-120m-private-placement-financing

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.